Nanoparticles and antigen delivery: understanding the benefits and drawbacks of different delivery platforms
Nanomedicine (Lond)
.
2014 Apr;9(4):373-6.
doi: 10.2217/nnm.14.16.
Authors
Nicholas O Fischer
1
,
Amy Rasley
,
Craig Blanchette
Affiliation
1
Biosciences & Biotechnology Division, Lawrence Livermore National Laboratory, Livermore, CA 94550, USA.
PMID:
24787434
DOI:
10.2217/nnm.14.16
No abstract available
Publication types
Editorial
MeSH terms
Animals
Antigens / administration & dosage*
Drug Carriers / chemistry*
Humans
Nanoparticles / chemistry*
Vaccines / administration & dosage*
Substances
Antigens
Drug Carriers
Vaccines